TY - JOUR
T1 - The ERA-EDTA Registry Annual Report 2018
T2 - A summary
AU - Kramer, Anneke
AU - Boenink, Rianne
AU - Stel, Vianda S.
AU - Santiuste de Pablos, Carmen
AU - Tomović, Filip
AU - Golan, Eliezer
AU - Kerschbaum, Julia
AU - Seyahi, Nurhan
AU - Ioanou, Kyriakos
AU - Beltrán, Palma
AU - Zurriaga, Oscar
AU - Magaz, Ángela
AU - Slon Roblero, María F.
AU - Gjorgjievski, Nikola
AU - Garneata, Liliana
AU - Arribas, Federico
AU - Galvão, Ana A.
AU - Bell, Samira
AU - Ots-Rosenberg, Mai
AU - Muñoz-Terol, José M.
AU - Winzeler, Rebecca
AU - Hommel, Kristine
AU - Åsberg, Anders
AU - Spustova, Viera
AU - Palencia García, María Ángeles
AU - Vazelov, Evgueniy
AU - Finne, Patrik
AU - ten Dam, Marc A. G. J.
AU - Lopot, František
AU - Trujillo-Alemán, Sara
AU - Lassalle, Mathilde
AU - Kolesnyk, Mykola O.
AU - Santhakumaran, Shalini
AU - Idrizi, Alma
AU - Andrusev, Anton
AU - Comas Farnés, Jordi
AU - Komissarov, Kirill
AU - Resić, Halima
AU - Palsson, Runolfur
AU - Kuzema, Viktorija
AU - Garcia Bazaga, Maria Angeles
AU - Ziginskiene, Edita
AU - Stendahl, Maria
AU - Bonthuis, Marjolein
AU - Massy, Ziad A.
AU - Jager, Kitty J.
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Background. The European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry collects data on kidney replacement therapy (KRT) via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article summarizes the 2018 ERA-EDTA Registry Annual Report, and describes the epidemiology of KRT for kidney failure in 34 countries. Methods. Individual patient data on patients undergoing KRT in 2018 were provided by 34 national or regional renal registries and aggregated data by 17 registries. The incidence and prevalence of KRT, the kidney transplantation activity and the survival probabilities of these patients were calculated. Results. In 2018, the ERA-EDTA Registry covered a general population of 636 million people. Overall, the incidence of KRT for kidney failure was 129 per million population (p.m.p.), 62% of patients were men, 51% were 65 years of age and 20% had diabetes mellitus as cause of kidney failure. Treatment modality at the onset of KRT was haemodialysis (HD) for 84%, peritoneal dialysis (PD) for 11% and pre-emptive kidney transplantation for 5% of patients. On 31 December 2018, the prevalence of KRT was 897 p.m.p., with 57% of patients on HD, 5% on PD and 38% living with a kidney transplant. The transplant rate in 2018 was 35 p.m.p.: 68% received a kidney from a deceased donor, 30% from a living donor and for 2% the donor source was unknown. For patients commencing dialysis during 2009-13, the unadjusted 5-year survival probability was 42.6%. For patients receiving a kidney transplant within this period, the unadjusted 5-year survival probability was 86.6% for recipients of deceased donor grafts and 93.9% for recipients of living donor grafts.
AB - Background. The European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry collects data on kidney replacement therapy (KRT) via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article summarizes the 2018 ERA-EDTA Registry Annual Report, and describes the epidemiology of KRT for kidney failure in 34 countries. Methods. Individual patient data on patients undergoing KRT in 2018 were provided by 34 national or regional renal registries and aggregated data by 17 registries. The incidence and prevalence of KRT, the kidney transplantation activity and the survival probabilities of these patients were calculated. Results. In 2018, the ERA-EDTA Registry covered a general population of 636 million people. Overall, the incidence of KRT for kidney failure was 129 per million population (p.m.p.), 62% of patients were men, 51% were 65 years of age and 20% had diabetes mellitus as cause of kidney failure. Treatment modality at the onset of KRT was haemodialysis (HD) for 84%, peritoneal dialysis (PD) for 11% and pre-emptive kidney transplantation for 5% of patients. On 31 December 2018, the prevalence of KRT was 897 p.m.p., with 57% of patients on HD, 5% on PD and 38% living with a kidney transplant. The transplant rate in 2018 was 35 p.m.p.: 68% received a kidney from a deceased donor, 30% from a living donor and for 2% the donor source was unknown. For patients commencing dialysis during 2009-13, the unadjusted 5-year survival probability was 42.6%. For patients receiving a kidney transplant within this period, the unadjusted 5-year survival probability was 86.6% for recipients of deceased donor grafts and 93.9% for recipients of living donor grafts.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85112286298&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/33564410
U2 - https://doi.org/10.1093/ckj/sfaa271
DO - https://doi.org/10.1093/ckj/sfaa271
M3 - Article
C2 - 33564410
SN - 2048-8505
VL - 14
SP - 107
EP - 123
JO - Clinical Kidney Journal
JF - Clinical Kidney Journal
IS - 1
ER -